BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 29, 2016
View Archived Issues
University of Queensland to develop a more accessible rotavirus vaccine
Read More
Rational Vaccines to start a phase I trial of Theravax HSV-2
Read More
ERO1LB shows promise as a therapeutic target for type 2 diabetes
Read More
Eisai submits label change application to FDA for antiepileptic drug Fycompa
Read More
Dicerna Pharmaceuticals to focus resources on GalXC technology platform
Read More
NASH FX trial of GR-MD-02 for NASH with advanced fibrosis does not meet primary biomarker endpoint
Read More
GM-CSF shows potential as a therapeutic target in multiple sclerosis
Read More
Actinium Pharmaceuticals starts phase II trial of Actimab-A in patients with AML
Read More
Takeda obtains NDA approval for Inisync fixed-dose combination tablets in Japan
Read More
IND submission for phase II trial of elafibranor in primary biliary cholangitis
Read More
Vectus Biosystems patents vasodilating agents
Read More
NCI awards SBIR contract to Cellerant Therapeutics
Read More
Pronai Therapeutics obtains exclusive license for PNT-737 from the CRT Pioneer Fund
Read More
Marketing approval for Galderma's Epiduo given by several European regulatory bodies
Read More
Pharmakea discloses ENPP2 inhibitors
Read More
French scientists describe FGFR3 inhibitors
Read More
DoD grant supports cardiac cell therapy trial in HFpEF
Read More
Merck & Co. develops IRAK-4 inhibitors
Read More
Medigene and bluebird bio collaborate on TCR immunotherapies
Read More
Enanta begins phase I trial of FXR agonist EDP-305 for NASH
Read More
FDA approves Orkambi for younger cystic fibrosis population
Read More
EGFL7 modulation shows potential for the treatment of MS and EAE
Read More
FDA places clinical hold on INDs for Alcobra's metaxodine
Read More
Parkinson's disease vaccine Affitope(R) PD-01A is boostable
Read More
Evotec signs collaboration with C4X Discovery Holdings
Read More
VSN-16R ameliorates spasticity without sedation in a MS model
Read More
Pernix announces U.S. distribution of Treximet for pediatric migraine patients
Read More